Drawing Strength From Music
Music can play a powerful role in helping patients find strength and comfort both during and after treatment. In this…
Blog - Melanoma360
04/12/2022
Drawing Strength From Music
Music can play a powerful role in helping patients find strength and comfort both during and after treatment. In this…
|
03/21/2022
Life After Loss: Lisa Huntley’s Life Has Come Full Circle
by Mara Klecker Lisa Huntley remembers walking out of the hospital without her husband, Grant, in 1994 and thinking to…
|
|
03/19/2022
FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma
CONTACT: Samantha Guild President AIM at Melanoma Foundation 916/206-6100 SGuild@AIMatMelanoma.org March 19, 2022 (Richmond, California) Yesterday, Bristol Myers Squibb announced…
|
03/09/2022
Building Psychological Resilience in the Face of Hereditary Risk
Living with hereditary cancer risk can be extremely stressful for all cancer patients. In this episode, Dr. Karen Hurley shares…
|
02/09/2022
Conversations About Immunotherapy and Caregiving
In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
|
01/27/2022
President’s Letter | January 2022
From the Desk of Samantha Guild Happy 2022! I hope this year is joyful and healthy for you and…
|
01/27/2022
In Plain English: The Results of DreamSeq
By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
|
01/26/2022
One Survivor Finds Empowerment through Education and Supporting Others
By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
|
01/26/2022
Become a Member of the Supporters Guild
“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
|
01/26/2022
FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma
January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024